This aligns with a reduction in their tumor-supportive functions.<h4>Conclusions</h4>Our findings provide a basis for improved high-risk patient stratification by highlighting a TrkB-based signature and generating prototype predictive models. The gene discussed is NTRK2; the disease is neoplasm.